Clinical Research Directory
Browse clinical research sites, groups, and studies.
Kratom Use Disorder Management Using Clonidine and/or Buprenorphine
Sponsor: Salem Anaesthesia Pain Clinic
Summary
Kratom is used for stimulant, analgesic, anxiolytic, and sedative effects. There is inadequate knowledge about Kratom addiction. Kratom withdrawal may be treated like opioid withdrawal. Prospective observational crossover study of consenting adults who are undergoing Kratom withdrawal management. On alternate weeks, each patient receives treatment using Buprenorphine 5cmg/hr patch; or Clonidine tablet 0.1mg 4hourly; or combined Clonidine tablet 0.1mg 4hourly + Buprenorphine 5cmg/hr patch. Each patient will undergo treatment for 12 weeks. Patients will use Subjective Opiate Withdrawal Scale (SOWS) to collect data on daily basis. SOWS is a patient-administered tool that is used to record the severity and presence of opiate withdrawal. The physician will also use Clinical Opiate Withdrawal Scale (COWS) to collect data on weekly basis. COWS is a clinician-administered tool that is used to record the signs of opiate withdrawal. A change in the COWS and SOWS scores by 6-points is considered significant.
Key Details
Gender
All
Age Range
20 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2018-07-02
Completion Date
2025-12-31
Last Updated
2025-01-27
Healthy Volunteers
Yes
Conditions
Interventions
Clonidine, Buprenorphine
Each patient receives rotational treatment using Buprenorphine 5cmg/hr patch; or Clonidine tablet 0.1mg 4hourly; or combined Clonidine tablet 0.1mg 4hourly + Buprenorphine 5cmg/hr patch.
Locations (1)
Salem Anaesthesia Pain Clinic
Surrey, British Columbia, Canada